Newly recognized lung macrophage protects chemotherapy-treated mice with a depleted immune system from lethal bacterial pneumonia
National Institutes of Health funding will help physicians and researchers improve hydroxyurea treatment management for sickle cell patients in Memphis.
The newly expanded Methodist Comprehensive Sickle Cell Center will strengthen research into sickle cell disease and serve the growing needs of patients in the Memphis area.
Proteinpaint database collaboration will make it easier for any scientist to explore cancer genome data.
The new doctoral program will focus on translational research and integrated approaches to discover better treatments and cures for pediatric diseases.
St. Jude researchers provide experimental evidence to demonstrate how stem cells contribute to cancer risk.
James Morgan, Ph.D., will lead the institution’s basic science programs
The Kids for Kids Family Fun Day for
St. Jude fundraiser in New York raised more than $1 million for
St. Jude during it's third consecutive year.
CBS Sports will assist
St. Jude in raising awareness of pediatric cancer throughout Childhood Cancer Awareness Month.
St. Jude Children’s Research Hospital calls for communities, leaders, supporters to help save lives of children battling cancer, other life-threatening diseases.
Golf and rock music fans came together to raise funds and awareness for
St. Jude Children’s Research Hospital at the sixth annual Scott Medlock – Robby Krieger
St. Jude Invitational & All-Star Concert.
St. Jude Hope in the Hamptons fundraiser in New York raised nearly $400,000 this year, bringing the total amount to more than $900,000 raised for
St. Jude in the last two years.
Researchers found a way to use genome editing to help fix sickle cell disease and beta-thalassemia in blood cells isolated from patients.
Molecular "master assassin" identified that recognizes flu-infected cells and triggers cell death, raises hope for drugs to prevent flu complications.
St. Jude Memphis to Peoria participants ran 465 miles, raising more than $5 million this year for
St. Jude, and more than $45.6 million since its inception 35 years ago.
NFL quarterback, Sam Bradford, hosted the 4th annual
St. Jude Sam Bradford Golf Classic, which has raised over $1 million for
St. Jude since its inception.
Variations in a porphyrin transport protein may affect symptom severity in patients with porphyria, a rare disorder of skin, liver and nervous system.
The addition of adjuvants to influenza vaccines offers no protection from severe flu infections in study looking at obesity.
Researchers develop “cumulative burden” statistical method to measure and address the impact of chronic disease in childhood cancer survivors
Influenza surveillance in migratory waterfowl suggests that highly pathogenic avian flu viruses do not persist in wild aquatic birds
Experts have developed a list of preferred terms to promote standardize reporting of pharmacogenetic test results in patients’ health records
Study shows that most teen cancer survivors do well psychologically, but cancer treatment may influence some survivors’ symptoms
Multifunctional protein Alix identified as essential for maintaining fluid balance in the brain; loss is linked to hydrocephalus.
Guests at the 11th annual
St. Jude Discover the Dream event raise funds and awareness for
St. Jude while learning about the world's wildlife at the Columbus Zoo and Aquarium.
The Department of Pathology has been accredited by The College of American Pathologists (CAP), a Centers for Medicare and Medicaid Services (CMS)-approved accreditation authority.
St. Jude scientist studying medulloblastoma is named Pew-Stewart Scholar for Cancer Research, which supports innovative early career researchers
Michael Dyer, Ph.D., to chair the department and build a team of international leaders in neural development, synapse formation and neural circuit formation.
Higher blood levels of methotrexate during treatment of childhood leukemia have been linked to diminished executive function in long-term survivors.
St. Jude experts present their research at the annual meeting of the American Society of Clinical Oncology in Chicago.
Preliminary report: Neuroblastoma tumors shrank in more pediatric patients when experimental immunotherapy was combined with chemotherapy